ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 143 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $48,000 | -18.6% | 13,200 | -34.0% | 0.00% | -50.0% |
Q1 2019 | $59,000 | -58.5% | 19,998 | -77.5% | 0.00% | -71.4% |
Q4 2018 | $142,000 | +238.1% | 88,995 | +687.0% | 0.01% | +250.0% |
Q3 2018 | $42,000 | -71.4% | 11,308 | -78.2% | 0.00% | -71.4% |
Q2 2018 | $147,000 | +188.2% | 51,910 | +193.4% | 0.01% | +133.3% |
Q4 2017 | $51,000 | -25.0% | 17,692 | +112.1% | 0.00% | -25.0% |
Q3 2016 | $68,000 | -21.8% | 8,340 | -24.9% | 0.00% | -20.0% |
Q2 2016 | $87,000 | +1.2% | 11,098 | 0.0% | 0.01% | 0.0% |
Q1 2016 | $86,000 | -28.3% | 11,098 | 0.0% | 0.01% | -28.6% |
Q4 2015 | $120,000 | +55.8% | 11,098 | 0.0% | 0.01% | +75.0% |
Q3 2015 | $77,000 | -21.4% | 11,098 | 0.0% | 0.00% | -20.0% |
Q2 2015 | $98,000 | -84.8% | 11,098 | -83.0% | 0.01% | -83.9% |
Q1 2015 | $643,000 | +312.2% | 65,240 | +413.4% | 0.03% | +287.5% |
Q4 2014 | $156,000 | -83.7% | 12,707 | -86.7% | 0.01% | -86.2% |
Q3 2014 | $957,000 | +369.1% | 95,892 | +256.0% | 0.06% | +383.3% |
Q2 2014 | $204,000 | – | 26,937 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |